The trade group says the denial does not settle its concerns about a law that limits minors' access to supplements marketed for weight loss or muscle building, and the case now returns to district court.
A panel at The Outlook on Active Nutrition discussed quality in sports nutrition focused on testing, liability, and what buyers now expect from suppliers.
Part 2 of our interview with Todd Harrison, co-chair of the FDA practice group at Venable LLP covers preclusion's structural gaps: no defined end point, no tracking registry, and a push for mandatory drug-sponsor engagement.
Todd Harrison, co-chair of the FDA practice group at Venable LLP, details the Dietary Supplement Innovation Act's language, its unintended consequences, and what industry stakeholders should watch for.
Piping Rock Health Products has launched a 300-mg NMN gummy under its Vitafusion brand, arriving less than a year after the FDA reversed its position on whether the ingredient could legally be sold as a dietary supplement.